Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.35% is 56% below its 5-year average of 7.68%, near the low end of its 5-year range (-1.50%–19.49%).
As of the fiscal period ended Sunday, December 28, 2025. 6.82% below its 12-month average of 3.59%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
3.35%
RETURN ON EQUITY (ROE) AVG TTM
3.59%
RETURN ON EQUITY (ROE) AVG 3Y
3.35%
RETURN ON EQUITY (ROE) AVG 5Y
7.68%
RETURN ON EQUITY (ROE) AVG 10Y
8.08%
RETURN ON EQUITY (ROE) AVG 15Y
8.03%
RETURN ON EQUITY (ROE) AVG 20Y
6.49%
CURRENT VS TTM AVG
-6.82%
CURRENT VS 3Y AVG
0.00%
CURRENT VS 5Y AVG
-56.40%
CURRENT VS 10Y AVG
-58.53%
CURRENT VS 15Y AVG
-58.30%
CURRENT VS 20Y AVG
-48.41%
SECTOR MEDIAN · HEALTHCARE
10.89%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-69.24%
vs the sector median at left
Revvity, Inc.
Market Cap
$12.55B
Return on Equity (ROE)
3.35%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
Market Cap
$12.11B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$13.51B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$11.45B
Return on Equity (ROE)
23.25%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$11.29B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.20B
Return on Equity (ROE)
-6.28%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
Market Cap
$14.10B
Return on Equity (ROE)
2.86%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$14.80B
Return on Equity (ROE)
28.82%
TTM Avg
23.51%
3Y Avg
17.50%
5Y Avg
13.68%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $12.55B | 3.35% | 3.59% | 3.35% | 7.68% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.77% | 10.54% | 10.84% | 19.93% |
| Baxter International Inc. (BAX)vs › | $13.51B | -17.13% | -12.46% | -8.76% | -1.37% |
| Insulet Corp. (PODD)vs › | $11.45B | 23.25% | 25.41% | 19.99% | 14.02% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 5.25% | 5.98% | 10.62% | 11.34% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | -6.28% | -2.13% | 6.32% | 9.65% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 2.86% | 4.70% | 4.67% | 11.22% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Solventum Corporation (SOLV)vs › | $14.80B | 28.82% | 23.51% | 17.50% | 13.68% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | -0.17% | 18.91% | 22.60% | 24.60% |
ROE
3.4%
ROA
2.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-28 | 3.33% |
| 2024-12-29 | 3.86% |
| 2023-12-31 | -1.50% |
| 2022-12-31 | 7.71% |
| 2021-12-31 | 13.21% |
| 2020-12-31 | 19.49% |
| 2019-12-31 | 8.09% |
| 2018-12-31 | 9.24% |
| 2017-12-31 | 4.51% |
| 2016-12-31 | 10.85% |
| 2015-12-31 | 10.07% |
| 2014-12-31 | 7.74% |
| 2013-12-31 | 8.42% |
| 2012-12-31 | 3.53% |
| 2011-12-31 | 0.06% |
| 2010-12-31 | 19.94% |
| 2009-12-31 | 5.25% |
| 2008-12-31 | 8.19% |
| 2007-12-31 | 8.44% |
| 2006-12-31 | 7.43% |
| 2005-12-31 | 4.95% |
| 2004-12-31 | 5.20% |
| 2003-12-31 | 3.93% |
| 2002-12-31 | -0.33% |
| 2001-12-31 | -0.05% |
| 2000-12-31 | 12.43% |
| 1999-12-31 | 5.16% |
| 1998-12-31 | 25.52% |
| 1997-12-31 | 10.27% |
| 1996-12-31 | 16.49% |
